(02) 9926 4726

News and Event

Implementation Research _ Seed Funding Round 2 – CLOSED

ABOUT THE EOI

Sydney Vital is calling for proposals for implementation research pilot projects via an Expression of Interests (EOI) process.

This expression of interest (EOI) may include (but are not limited to) the following themes:

  •  Educate Sydney Vital member network on implementation (T3) of evidence based supportive care strategies for cancer symptoms and treatment side effects.
  •  Develop Health Professional Education modules using e-learning techniques which can be made available to clinicians in NSW.
  •  Identify new clinical pathways or techniques based on the evidence based guidelines suitable for implementation
  •  Test methods for delivery of psychosocial support and reduction of treatment toxicity
  •  Identify ways to improve management of survivorship issues in cancer patients including cognitive dysfunction.
  •  Implement communication skills training or other self- care strategies for staff working with late stage cancer patients.
  •  Test new methods of care or prognostic factors for patients with late stage cancer.

FUNDING AVAILABLE

Up to $25,000 in funding to support the undertaking of an implementation research project. The funding must be spent within 12 months of receiving the award. Management team may allocate funding to one or more implementation research projects in the 2015-2016 calendar year.

For further information: Implementation Research_Seed Funding Round 2

Read more

Implementation Research Seed Funding Round 2

ABOUT THE EOI

Sydney Vital is calling for proposals for implementation research pilot projects via an Expression of Interests (EOI) process.

This expression of interest (EOI) may include (but are not limited to) the following themes:

  •  Educate Sydney Vital member network on implementation (T3) of evidence based supportive care strategies for cancer symptoms and treatment side effects.
  •  Develop Health Professional Education modules using e-learning techniques which can be made available to clinicians in NSW.
  •  Identify new clinical pathways or techniques based on the evidence based guidelines suitable for implementation
  •  Test methods for delivery of psychosocial support and reduction of treatment toxicity
  •  Identify ways to improve management of survivorship issues in cancer patients including cognitive dysfunction.
  •  Implement communication skills training or other self- care strategies for staff working with late stage cancer patients.
  •  Test new methods of care or prognostic factors for patients with late stage cancer.

FUNDING AVAILABLE

Up to $25,000 in funding to support the undertaking of an implementation research project. The funding must be spent within 12 months of receiving the award. Management team may allocate funding to one or more implementation research projects in the 2015-2016 calendar year.

For further information: Implementation Research_Seed Funding Round 2

Read more

Research Scholarship Awards Round 3 – CLOSED

Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $15,000 each for one year to students, preclinical and clinical researchers working in the area of Translational Cancer Research. These awards are to be used to support the research and are to be spent at the discretion of the student and their supervisor(s).

Key Dates for Round 3

Call for Applications: 1 September 2015

Closing Date for Applications: 1 October 2015

Announcement of Outcome: 1 November 2015

Sydney Vital_Research Scholar Award_Guidelines_Round 3_2015

Sydney Vital Research Scholarship_General Feedback_Round 2

Other Grant Opportunities

Read more

Implementation Research Pilot projects – CLOSED

CALL FOR EOI’S

Sydney Vital is calling for proposals for implementation research pilot projects via an Expression of Interests (EOI) process.
Sydney Vital will provide financial support for a number of implementation research projects in the 2015 calendar year.

This expression of interest (EOI) may include (but are not limited to) the following themes:
• Educate Sydney Vital member network on implementation (T3) of evidence based supportive care strategies for cancer symptoms and treatment side effects.
• Develop Health Professional Education modules using e-learning techniques which can be made available to clinicians in NSW.
• Identify new clinical pathways or techniques based on the evidence based guidelines suitable for implementation
• Test methods for delivery of psychosocial support and reduction of treatment toxicity
• Evaluating new approaches to breast reconstruction and their impact on Quality of Life (QoL).
• Identify ways to improve management of survivorship issues in cancer patients.
• Test new methods of care or prognostic factors for patients with late stage cancer.

FUNDING AVAILABLE
Up to $25,000 in funding to support the undertaking of an implementation research project. The funding must be spent within 12 months of receiving the award. Management team may allocate funding to one or more projects.

Read More: Implementation Research_Seed Funding 2015_EOI
Closing Date for EOI’s: Friday, 5 June 2015

Read more

Supportive care, end stage tumour, and end-of life management – CLOSED

CALL FOR EOI’S FOR PILLAR LEADERS

Sydney Vital is seeking 2 individuals to act as leader for Pillar 4:
“Supportive care, end stage tumours, and end-of life management”. The Pillar’s aims are deliberately broad to allow scope to explore and exploit strengths within the partner organisations. The Pillar provides base funding of $10 k p.a. (which can be further leveraged) to support activities to bring Pillar members together to develop new programs of research, both basic science and clinical, and to expand networks and collaborations. Ideally, the Pillars would have outputs that impact on the T1, T2 and T3 domains of translational research as defined by the CINSW, or the Sydney Vital Flagship Programs 1, 2, or 3 (www.sydneyvital.org.com). The Pillar leader is ideally an early to mid-career researcher who is currently developing their research portfolio.

Read More: Pillar 4 EOI_ 2015
Closing Date for EOI’s: Friday, 5th June 2015

Read more

Flagship 1 Seed Funding – CLOSED

The Sydney Vital Flagship 1 program has up to $25,000 available to encourage the development of new research ideas in preclinical studies of treatment-resistant cancers. Projects should concern
(i) new therapies for treatment-resistant cancers, or
(ii) the identification of new biomarkers of treatment resistance.

Applications are sought from Sydney Vital members for two 1-year grants of up to $12,000 each in either of the above areas. Each applicant may submit only one application in this funding round. These grants are not intended to support the extension or expansion of existing research projects, but are to seed new ideas, with the goal of generating data to a point where external funding may be sought.

Read More: Sydney Vital Flagship 1 SEED FUNDING

Closing date: Sunday, 17th May 2015

Read more

Research Scholarship Awards 2015

SYDNEY VITAL is pleased to offer 4 x Research Scholarship Awards to the value of $15,000 each for one year to students, preclinical and clinical researchers working in the area of translational cancer research. These awards are to be used to support the research and are to be spent at the discretion of the student and their supervisor(s).
Closing date for applications: Friday, 15th May 2015.
Read more: Sydney Vital_Research Scholar Award_Guidelines_Final_2015

Read more

Understanding and Overcoming Mechanisms of Drug Resistance in Tumours

CALL FOR EOI’S FOR PILLAR LEADERS

Sydney Vital is seeking 2 individuals to act as leaders for Pillar 3 – “Understanding and Overcoming Mechanisms of Drug Resistance in Tumours”. The Pillar’s aims are deliberately broad to allow scope to explore and exploit strengths within the partner organisations. The Pillar provides base funding of $15 k p.a. (which can be further leveraged) to support activities to bring Pillar members together to develop new programs of research, both basic science and clinical, and to expand networks and collaborations. Ideally, the Pillars would have outputs that impact on the T1, T2 and T3 domains of translational research as defined by the CINSW, or the Flagship Programs 1, 2, or 3 of Sydney Vital . The Pillar leaders would ideally be researchers who are currently developing their research portfolio and might be classified as early to mid-career researchers. A clinician and a basic/pre-clinical scientist is the preferred combination of Sydney Vital.
Closing date for EOI: Thursday, 30th April 2015. Read more: SYDNEY VITAL_Pillar Leads 3_EOI

Read more

Determining why and when early stage cancer recurs

CALL FOR EOI’S FOR PILLAR LEADERS

Sydney Vital_EoI_Pillar 2 Lead 2015_V01

Read more

Defining and Achieving State-of-the-Art Cancer Diagnosis and Treatment

CALL FOR EOI’S FOR PILLAR LEADERS

EoI - Pillar Lead 2015 V1 1

Read more